Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$161.01 - $317.85 $3.97 Million - $7.83 Million
24,649 Added 4.52%
569,722 $180 Million
Q3 2023

Nov 13, 2023

BUY
$164.66 - $218.08 $10 Million - $13.3 Million
60,926 Added 12.58%
545,073 $92.2 Million
Q2 2023

Aug 11, 2023

SELL
$176.32 - $240.22 $20.9 Million - $28.4 Million
-118,288 Reduced 19.63%
484,147 $105 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $10.6 Million - $13.5 Million
65,948 Added 12.29%
602,435 $109 Million
Q4 2022

Feb 13, 2023

BUY
$191.53 - $236.82 $5.87 Million - $7.26 Million
30,636 Added 6.06%
536,487 $105 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $10.1 Million - $22.6 Million
81,451 Added 19.19%
505,851 $114 Million
Q2 2022

Aug 12, 2022

BUY
$93.97 - $143.33 $2.49 Million - $3.8 Million
26,525 Added 6.67%
424,400 $53.7 Million
Q1 2022

May 13, 2022

BUY
$98.9 - $132.37 $988,703 - $1.32 Million
9,997 Added 2.58%
397,875 $50.4 Million
Q4 2021

Feb 11, 2022

BUY
$110.64 - $159.4 $2.16 Million - $3.11 Million
19,523 Added 5.3%
387,878 $50.8 Million
Q3 2021

Nov 12, 2021

BUY
$101.2 - $125.87 $949,660 - $1.18 Million
9,384 Added 2.61%
368,355 $45.1 Million
Q2 2021

Aug 13, 2021

BUY
$107.45 - $135.95 $6.9 Million - $8.73 Million
64,233 Added 21.79%
358,971 $40.9 Million
Q1 2021

May 12, 2021

BUY
$95.46 - $133.08 $3.72 Million - $5.18 Million
38,941 Added 15.22%
294,738 $35.4 Million
Q4 2020

Feb 12, 2021

BUY
$75.23 - $109.23 $533,455 - $774,549
7,091 Added 2.85%
255,797 $26 Million
Q3 2020

Nov 13, 2020

BUY
$71.31 - $109.74 $3.1 Million - $4.77 Million
43,423 Added 21.15%
248,706 $19.2 Million
Q2 2020

Aug 13, 2020

BUY
$62.14 - $117.21 $2.18 Million - $4.11 Million
35,063 Added 20.6%
205,283 $22.9 Million
Q1 2020

May 14, 2020

BUY
$60.41 - $115.92 $4.92 Million - $9.44 Million
81,418 Added 91.68%
170,220 $12.3 Million
Q4 2019

Feb 13, 2020

BUY
$11.44 - $123.99 $217,932 - $2.36 Million
19,050 Added 27.31%
88,802 $6.69 Million
Q3 2019

Nov 12, 2019

BUY
$16.05 - $27.35 $1.12 Million - $1.91 Million
69,752 New
69,752 $1.14 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.